Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Finished Goods (2016 - 2024)

Utah Medical Products (UTMD) has 14 years of Finished Goods data on record, last reported at $1.9 million in Q4 2024.

  • For Q4 2024, Finished Goods rose 13.53% year-over-year to $1.9 million; the TTM value through Dec 2024 reached $1.9 million, up 13.53%, while the annual FY2024 figure was $1.9 million, 13.53% up from the prior year.
  • Finished Goods reached $1.9 million in Q4 2024 per UTMD's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Finished Goods topped out at $2.5 million in Q2 2023 and bottomed at $1.1 million in Q2 2021.
  • Average Finished Goods over 5 years is $1.6 million, with a median of $1.5 million recorded in 2021.
  • Peak YoY movement for Finished Goods: tumbled 61.01% in 2020, then skyrocketed 55.36% in 2023.
  • A 5-year view of Finished Goods shows it stood at $1.4 million in 2020, then increased by 7.7% to $1.5 million in 2021, then increased by 29.16% to $1.9 million in 2022, then decreased by 11.13% to $1.7 million in 2023, then rose by 13.53% to $1.9 million in 2024.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $1.9 million in Q4 2024, $1.4 million in Q3 2024, and $1.3 million in Q2 2024.